Using human induced pluripotent stem cells to model a novel nonsense mutation of RYR2 and identify potential therapeutic agents for patients with CPVT. (July 2018) - Hopton, C.; Tijsen, A.J.; Maizels, L.; Huber, I.; Arbel, G.; Gepstein, A.; Gepstein, L.; Newman, W.G.; Venetucci, L.